ATNF: 180 Life Sciences Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 47.24
Enterprise Value ($M) 49.15
Book Value ($M) 5.00
Book Value / Share 0.91
Price / Book 9.88
NCAV ($M) -2.31
NCAV / Share -0.42
Price / NCAV -21.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.00
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 0.34

Balance Sheet (mrq) ($M)
Current Assets 1.19
Assets 12.63
Liabilities 3.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -1.21
Net Income -0.09
Earnings Per Share Diluted -0.02
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description n/a
Earnings Per Share Basic -0.02

Cash Flow Statement (mra) ($M)
Cash From Operations -1.45
Cash from Investing 108.24
Cash from Financing 108.24

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-12-01 92,325 372,900 24.76
2020-11-30 120,026 415,466 28.89
2020-11-27 204,810 618,285 33.13

(click for more detail)

Similar Companies
ASRT – Assertio Therapeutics, Inc. (DE) ATHA – Athira Pharma, Inc.
ATHX – Athersys, Inc. ATNX – Athenex Inc.
ATOS – Atossa Genetics Inc


Financial data and stock pages provided by
Fintel.io